Search research articles
Contact Us
Filters
Showing results (591-600 of 993) with videos related to
Page
of 100
Sort By:
Urologic Oncology
|
October 23, 2021
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma
Rocco Simone Flammia, Francesco Chierigo, Christoph Würnschimmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 23, 2017
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
Glenn Heller, Robert McCormack, Thian Kheoh, et al.
Prostate Cancer and Prostatic Diseases
|
May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Minerva Urology and Nephrology
|
April 23, 2021
Improving the stratification of intermediate risk prostate cancer
Luigi Nocera, Claudia Collà Ruvolo, Lara F Stolzenbach, et al.
European Urology
|
March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium
Felix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Cancer Causes & Control : CCC
|
September 3, 2021
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
Mike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, et al.
Communications Biology
|
September 8, 2021
CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis
Chahat Mehra, Ji-Hyun Chung, Yi He, et al.
The Prostate
|
November 6, 2022
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5
Andrea Panunzio, Gabriele Sorce, Benedikt Hoeh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients
Lara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, et al.
Urologic Oncology
|
September 20, 2020
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates
Claudia Collà Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, et al.
Page
of 100
Search research articles
Search
Showing results (591-600 of 993) with videos related to
Sort By:
Page
of 100
Urologic Oncology
|
October 23, 2021
Survival benefit of chemotherapy in a contemporary cohort of metastatic urachal carcinoma
Rocco Simone Flammia, Francesco Chierigo, Christoph Würnschimmel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 23, 2017
Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
Glenn Heller, Robert McCormack, Thian Kheoh, et al.
Prostate Cancer and Prostatic Diseases
|
May 31, 2021
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, et al.
Minerva Urology and Nephrology
|
April 23, 2021
Improving the stratification of intermediate risk prostate cancer
Luigi Nocera, Claudia Collà Ruvolo, Lara F Stolzenbach, et al.
European Urology
|
March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium
Felix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
Cancer Causes & Control : CCC
|
September 3, 2021
Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
Mike Wenzel, Nicolas Siron, Claudia Collà Ruvolo, et al.
Communications Biology
|
September 8, 2021
CdGAP promotes prostate cancer metastasis by regulating epithelial-to-mesenchymal transition, cell cycle progression, and apoptosis
Chahat Mehra, Ji-Hyun Chung, Yi He, et al.
The Prostate
|
November 6, 2022
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5
Andrea Panunzio, Gabriele Sorce, Benedikt Hoeh, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 5, 2020
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients
Lara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, et al.
Urologic Oncology
|
September 20, 2020
Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates
Claudia Collà Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, et al.
Page
of 100